These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 26749278
21. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy. Bellur SS, Troyanov S, Vorobyeva O, Coppo R, Roberts ISD, Validation in IgA Nephropathy study group. Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992 [Abstract] [Full Text] [Related]
22. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy. Trimarchi H, Coppo R. Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265 [Abstract] [Full Text] [Related]
23. The putative role of MALDI-MSI in the study of Membranous Nephropathy. Smith A, L'Imperio V, Ajello E, Ferrario F, Mosele N, Stella M, Galli M, Chinello C, Pieruzzi F, Spasovski G, Pagni F, Magni F. Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):865-874. PubMed ID: 27890680 [Abstract] [Full Text] [Related]
24. Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Achenbach J, Mengel M, Tossidou I, Peters I, Park JK, Haubitz M, Ehrich JH, Haller H, Schiffer M. Nephrol Dial Transplant; 2008 Oct; 23(10):3138-45. PubMed ID: 18458033 [Abstract] [Full Text] [Related]
25. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Chen CA, Hwang JC, Guh JY, Chang JM, Lai YH, Chen HC. J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165 [Abstract] [Full Text] [Related]
26. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis. Pérez V, Ibernón M, López D, Pastor MC, Navarro M, Navarro-Muñoz M, Bonet J, Romero R. PLoS One; 2014 Feb; 9(1):e87731. PubMed ID: 24498182 [Abstract] [Full Text] [Related]
27. Abnormal expression of glomerular basement membrane laminins in membranous glomerulonephritis. Fischer E, Mougenot B, Callard P, Ronco P, Rossert J. Nephrol Dial Transplant; 2000 Dec; 15(12):1956-64. PubMed ID: 11096140 [Abstract] [Full Text] [Related]
28. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children. Tamura H, Nakazato H, Kuraoka S, Yoneda K, Takahashi W, Endo F. Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224 [Abstract] [Full Text] [Related]
29. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis. Xiao B, Wang LN, Li W, Gong L, Yu T, Zuo QF, Zhao HW, Zou QM. Cell Death Dis; 2018 May 01; 9(5):533. PubMed ID: 29748623 [Abstract] [Full Text] [Related]
30. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY. Nephrol Dial Transplant; 2009 Aug 01; 24(8):2406-10. PubMed ID: 19264742 [Abstract] [Full Text] [Related]
31. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy. Deegens JK, Wetzels JF. Minerva Urol Nefrol; 2005 Sep 01; 57(3):211-36. PubMed ID: 15986018 [Abstract] [Full Text] [Related]
32. [Expression of neonatal Fc receptor on human nephritis and rat nephritis models]. Feng ST, Gan HL, Sun JY, Jiang T, Liu BL, Zhao ZH, Guo MY, Zhang ZG. Zhonghua Bing Li Xue Za Zhi; 2012 Feb 01; 41(2):81-5. PubMed ID: 22455882 [Abstract] [Full Text] [Related]
33. Novel biomarkers in glomerular disease. Caliskan Y, Kiryluk K. Adv Chronic Kidney Dis; 2014 Mar 01; 21(2):205-16. PubMed ID: 24602470 [Abstract] [Full Text] [Related]
34. Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases. Navarro-Muñoz M, Ibernon M, Bonet J, Pérez V, Pastor MC, Bayés B, Casado-Vela J, Navarro M, Ara J, Espinal A, Fluvià L, Serra A, López D, Romero R. Kidney Blood Press Res; 2012 Mar 01; 35(5):314-25. PubMed ID: 22399069 [Abstract] [Full Text] [Related]
35. Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China. Guo SM, Han M, Chen MX, Ning Y, Pei GC, Li YQ, Dai W, Ge SW, Deng YJ, Guo YY, Li XQ, Haller H, Xu G, Rong S. PLoS One; 2015 Mar 01; 10(9):e0138718. PubMed ID: 26380984 [Abstract] [Full Text] [Related]
36. [Clinical and pathological features of IgA nephropathy in west Guangdong province]. Chen WL, Lin HP, Liu HF. Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 01; 30(5):1150-1. PubMed ID: 20501418 [Abstract] [Full Text] [Related]
37. The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies. Rosenberg AZ, Palmer M, Merlino L, Troost JP, Gasim A, Bagnasco S, Avila-Casado C, Johnstone D, Hodgin JB, Conway C, Gillespie BW, Nast CC, Barisoni L, Hewitt SM. PLoS One; 2016 May 01; 11(6):e0156441. PubMed ID: 27310011 [Abstract] [Full Text] [Related]
38. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies. Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K. Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605 [Abstract] [Full Text] [Related]
39. Primary glomerulonephritis in mainland China: an overview. Xie J, Chen N. Contrib Nephrol; 2013 Feb 15; 181():1-11. PubMed ID: 23689562 [Abstract] [Full Text] [Related]
40. Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis. Aparecida da Silva C, Molinar Mauad Cintra M, de Castro Côbo E, Vinícius da Silva M, Bichuette Custódio F, Rosa Miranda Corrêa R, Roberto Castellano L, Antônia dos Reis M, Reis Machado J. Dis Markers; 2014 Feb 15; 2014():192836. PubMed ID: 24719498 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]